Alzheimer´s disease (AD), characterized by the death of nerve cells in the cerebral cortex, is the most common subtype of dementia. Despite the exponential growth in the number of AD patients, acetylcholinesterase (AChE) inhibitors are currently used to treat AD. Plants of the Amaryllidaceae family are known to synthesize a particular type of bioactive compounds, named Amaryllidaceae alkaloids, which have shown AChE inhibitory activity. Alkaloid extracts of three species of Amaryllidaceae were studied with respect to their acetylcholinesterase and butyrylcholinesterase inhibitory activity and alkaloid patterns. Eleven alkaloids were identified by GC/MS. Significant cholinesterase inhibitory activity was demonstrated by the alkaloid extract of N. undulata (IC 50,HuAChE = 14.3 ± 1.2 µg/mL; IC 50,HuBuChE = 33.9 ± 1.9 µg/mL).
Alzheimer´s disease (AD) is the most common neurodegenerative disease and the leading cause for cognitive decline in the elderly. The disease results in the relentless progressive decline in intellectual function and gradual loss of the activities of daily living. AD has two characteristic pathological hallmarks, senile plaques (SPs) and neurofibrillary tangles (NFTs). SPs are an extracellular accumulation of beta-amyloid (Aß) surrounded by dystrophic neurites and microglia [1] . NFTs are the intraneuronal accumulation of paired helical filaments (PHFs) with hyperphosphorylated tau being the major protein subunits of PHFs [2] . In AD patients, deficit of cholinergic functions, which results in decreased levels of the neurotransmitter acetylcholine (ACh) in the cortex, is responsible for the memory impairments [3] . The principal role of acetylcholinesterase (AChE) is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of acetylcholine (ACh). In humans, not only AChE participates in the cholinergic regulation of the central nervous system (CNS), but also another enzyme, butyrylcholinesterase (BuChE), which is able to hydrolyze ACh among other ester compounds [4] . BuChE is associated with the NFTs and SPs and its activity increases in the AD brain, where it co-localizes with Aß fibrils [5] . In severe AD, levels of AChE and choline acetyltransferase are decreased by as much as 90% compared with normal, whilst BuChE increases [6] . This fact has targeted BuChE as a new approach to intercede in the progression of AD and requires research into new inhibitors with dual enzymatic activity. Currently, acetylcholinesterase inhibition is the most used therapeutic treatment for the symptoms of AD [7, 8] .
Amaryllidaceae species are known as ornamental plants and produce structurally unique alkaloids with a wide range of interesting physiological effects, including antitumor, antiviral, cholinesterase inhibitory, immune stimulatory and antimalarial [9] [10] [11] . Some species of this family contain galanthamine, a long acting, selective, reversible and competitive acetylcholinesterase (AChE) inhibitor approved for the treatment of Alzheimer´s disease [12] . The search for more potent and effective AChE inhibitors from natural sources has led to the isolation of other Amaryllidaceae alkaloids, such as sanguinine, habranthine and 1-O-acetyllycoryne, which possess either similar or stronger activity than galanthamine [10] . A wide range of Amaryllidaceae species has been extensively used in traditional medicine to treat a variety of health problems.
Alkaloids of many different skeleton types can be rapidly identified by GC/EI-MS [13] [14] [15] . It has been found that Amaryllidaceae alkaloids can be analyzed by GC without derivatization and, with only few exceptions, they show a mass spectral fragmentation pattern very similar to those obtained under direct insertion [14] . In some cases, the GC/MS screening of plant samples has revealed compounds with unknown mass spectra, which has resulted in the isolation and spectroscopic identification of new natural bioactive molecules [16] .
In the present work we report the GC/MS investigations of the alkaloid extracts from the bulbs of Nerine undulata (L). Herb., Scadoxus multiflorus (Martyn) Raf. and Sprekelia formosissima (L.) Herb., and the inhibitory effect of these extracts on the activity of human erythrocytic AChE (HuAChE) and plasma BuChE (HuBuChE).
In the bulb extracts of the studied species, thirteen alkaloids of the crinine, haemanthamine and tazettine type were detected by GC/MS, eleven of which were identified based on their retention times and mass spectra as buphanidrine (1), buphanamine (2), montanine (3), haemanthamine (4), tazettine (5), flexinine (6), undulatine (7) , ambelline (8), 3-epimacronine (10), crinamidine (11) and bowdensine (13) . The mass spectra of compounds 9 and 12 were not found either in the databases or in the literature. For the identification of these compounds, which were major components of the alkaloid extract of N. undulata (10 % and 9 % of TIC, respectively), isolation in larger amount and structure elucidation by spectral methods is needed. The relative proportion of each alkaloid was determined as a percentage of the total ion current (TIC). The area of the GC/MS peaks depends not only on the corresponding compounds, but also on the intensity of their MS fragmentation, so the data given in the Table 1 are not true quantification. However, they can be used for comparison between samples.
The genus Nerine, the second largest within the Amaryllidaceae with ca 30 species, is an autumn-flowering perennial bulbous plant group, whose species inhabit areas with summer rainfall and cold, dry winters [17] . Previous phytochemical investigation of N. undulata led to the isolation and identification of three alkaloids (lycorine, ambelline and undulatine) [18] . The alkaloid pattern of N. undulata in our study was dominated by two crininetype alkaloids: undulatine (5, 6% of TIC), buphanamine (2, 11% of TIC) and two unidentified (9, 12, 10% and 9% of TIC, respectively) alkaloids. The alkaloid extract from N. undulata possessed a promising activity against HuAChE with an IC 50 value of 14.3 ± 1.2 µM ( Table 2) . It is reported in the literature that, among the plants of the family Amaryllidaceae, AChE inhibitory activity is associated mainly with galanthamine and lycorine type alkaloids [10, 19] . Lycorine-type compounds are less active inhibitors than the galanthamine-type and their activity is associated with substitution at positions C-1 and C-2 [10] . Crinine-type alkaloids have only a weak activity against AChE and it appears that the stereochemistry of the 5,10b-ethanobridge has no effect on the inhibition of AChE activity [20] . Based on these conclusions and our results, it is possible that the promising HuAChE inhibition 
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The extract of N. undulata also showed significant HuBuChE inhibition activity with an IC 50 value of 33.9 ± 1.9 µg/mL. As mentioned above, BuChE plays an important role in the late stages of AD. In such instances, it is possible that BuChE may be a more appropriate therapeutic target, but only a limited number of alkaloids have been tested for their BuChE inhibition activity so far. There are no data on the BuChE inhibition activity of pure Amaryllidaceae alkaloids.
Alkaloid extracts of Scadoxus multiflorus and Sprekelia formossissima showed only weak HuAChE inhibition activity. HuBuChE inhibition activity, better than the standard galanthamine, was demonstrated by the extract of S. multiflorus with an IC 50 value of 54.3 ± 3.1 µg/mL. In this species we identified only two alkaloids: montanine and undulatine. The alkaloid profile of S. formosissima was dominated by haemanthamine (4) and tazettine (5). 
Extraction of alkaloids:
Fresh bulbs (3 x 15 g) were extracted 3 times with EtOH (50 mL) at room temperature for 24 h. The solvent was evaporated under reduced pressure and the residue dissolved in 10 mL 2% HCl. After removing the neutral compounds with diethyl ether (3 x 15 mL), the extract was basified with 25% ammonia solution and the alkaloids extracted with EtOAc (3 x 15 mL). The organic solvent was evaporated and 10 mg of each alkaloid extract was removed for acetylcholinesterase and butyrylcholinesterase assay. The rest of the dry alkaloid fraction was dissolved in MeOH to a final concentration of 10 mg/mL for further analysis.
GC/MS analysis and identification of alkaloids:
The GC/MS analysis of underivatized alkaloids was carried out on a gas chromatograph (Focus Thermo Scientific, USA) with a splitless injector (280°C) and a mass detector (200°C, GC-MS MD 800 Fisons, Manchester, UK). A DB-5MS column (30 m x 0.25 mm x 0.25 μm, Agilent Technologies Santa Clara, CA, USA) was used for separation. The temperature program was: 100 -180°C at 15°C/min, 1 min hold at 180°C, and 180 -300°C at 5°C /min and 5 min hold at 300°C, detection range m/z 40-600. The injector temperature was 280°C. The flow-rate of carrier gas (helium) was 1 mL/min. A split ratio of 1:10 was used. The alkaloidal solution (1 μL) was injected. The alkaloids were identified by comparison of their MS with those in the NIST library, with those reported in the literature [16, 22, 23] , and with reference compounds isolated earlier in our laboratory (galanthamine, haemanthamine, tazettine).
Preparation of red blood cells ghosts:
Ghosts were prepared from freshly drawn blood (taken from healthy volunteers), to which 1 mL of sodium citrate per 10 mL of blood was added, according to the method of Steck and Kant [24] , with slight modification. Briefly, plasma (HuBuChE) was removed from the whole blood by centrifugation at 4000 rpm in a Boeco U-32R centrifuge with a Hettich 1611 rotor. Red blood cells were transferred to 50 mL tubes and washed 3 times with 5 mM phosphate buffer (pH 7.4) containing 150 mM sodium chloride (12000 rpm, Avanti J-30I, rotor JA-30.50). The washed erythrocytes were stirred with 5 mM phosphate buffer (pH 7.4) for 10 mins to ensure lysis. The lysed cells were centrifuged at 20,000 rpm for 10 mins and then the ghosts (HuAChE) were washed 3 times with phosphate buffer.
Acetylcholinesterase and butyrylcholinesterase assay:
HuAChE and HuBuChE activities were determined using a modified method of Ellman et al. [25] at concentrations of 0.5, 2.5, 5, 12.5, 25, 50, 125, 250 and 500 μg/mL using acetylthiocholine iodide and butyrylthiocholine iodide as substrates, respectively. Briefly, 25-50 μL of either ghosts or plasma, 650 μL of DTNB and 25 μL of either the sample or appropriate solvent, as a blank sample, were added to the semi-micro cuvette. The reaction was initiated by addition of substrate (ATChI or BuTChI). The final proportion of DTNB to substrate was 1:1. The increase of absorbance at 436 nm (∆A) was measured for 1 min using a Shimadzu UV-1611 spectrophotometer. Each measurement was repeated 3 times. Galanthamine and huperzine A were used as positive standards [21] . The % inhibition was calculated according to the formula: %I = 100-(∆A BL /∆A SA )*100, where ∆A BL is increase of absorbance of blank sample and ∆A SA is increase of absorbance of the measured sample.
Statistical analysis:
The IC 50 values were calculated with the use of GraphPad Prism 5.02 software.
